Cargando…
Efficacy and Safety of Botulinum Toxin Type A (NABOTA) for Post-stroke Upper Extremity Spasticity: A Multicenter Phase IV Trial
OBJECTIVE: To evaluate the efficacy and safety of Daewoong botulinum toxin type A (NABOTA) after its launch in South Korea. METHODS: This prospective, multicenter, open-label phase IV clinical trial included 222 patients with stroke. All patients visited the clinic at baseline and at weeks 4, 8, and...
Autores principales: | Hwang, Wonjae, Kang, Seong Min, Lee, Sang Yoon, Seo, Han Gil, Park, Yoon Ghil, Kwon, Bum Sun, Lee, Kwang Jae, Kim, Deog Young, Kim, Hyoung Seop, Lee, Shi-Uk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Rehabilitation Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452292/ https://www.ncbi.nlm.nih.gov/pubmed/36070998 http://dx.doi.org/10.5535/arm.22061 |
Ejemplares similares
-
Safety, efficacy, and onset of a novel botulinum toxin type A (Nabota) for the treatment of glabellar frown lines: a single-arm, prospective, phase 4 clinical study
por: Song, Sinyoung, et al.
Publicado: (2018) -
Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity
por: Yazdchi, Mohammad, et al.
Publicado: (2013) -
Botulinum Toxin Treatment on Upper Limb Function in School Age Children With Bilateral Spastic Cerebral Palsy: One Year Follow-up
por: Lee, Jee Sun, et al.
Publicado: (2013) -
Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity
por: Ghroubi, Sameh, et al.
Publicado: (2020) -
The Central Effects of Botulinum Toxin in Dystonia and Spasticity
por: Hok, Pavel, et al.
Publicado: (2021)